Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Cooperativity Of RUNX1 and CSF3R Mutations In The Development Of Leukemia In Severe Congenital Neutropenia: A Unique Pathway In Myeloid Leukemogenesis

Blood (2013) 122 (21): 444.

https://doi.org/10.1182/blood.V122.21.444.444

Published: 2013

Journal Articles

Whole Exome Sequencing In Relapsed Pediatric T-ALL: Progression Into Relapse Is Characterized By An Increased Number Of Somatic Mutations and a Conservation Of Mutations In Leukemogenic Driver Genes

Joachim Kunz, MD, Tobias Rausch, PhD, Obul R Bandapalli, PhD, Martina U. Muckenthaler, PhD, Adrian M Stuetz, PhD, Martin Stanulla, MD, MSc, Martin Schrappe, MD, Rupert Handgretinger, Smadar Avigad, PhD, Jan Korbel, PhD, Andreas E. Kulozik, MD, PhD

Blood (2013) 122 (21): 228.

https://doi.org/10.1182/blood.V122.21.228.228

Published: 2013

Journal Articles

Second Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia

Blood (2012) 120 (21): 661.

https://doi.org/10.1182/blood.V120.21.661.661

Published: 2012

Journal Articles

Novel Genomic Structural Variations in Relapsed Childhood ETV6/RUNX1 ( TEL/AML1 ) Acute Lymphoblastic Leukemias Identified by Next Generation Sequencing

Vera Okpanyi, PhD, Christoph Bartenhagen, MSc, Michael Gombert, PhD, Sebastian Ginzel, PhD, Pina Fanny Ida Krell, MSc, Peter Husemann, PhD, Cai Chen, MD, Vera Binder, MD, Jutta Bradtke, PhD, Andrea Teigler-Schlegel, PhD, Silja Roettgers, PhD, Jochen Harbott, PhD, Martin Stanulla, MD, MSc, Cornelia Eckert, PhD, Ralf Thiele, PhD, Martin Dugas, PhD, Arndt Borkhardt, MD, Ute Fischer, PhD

Blood (2012) 120 (21): 518.

https://doi.org/10.1182/blood.V120.21.518.518

Published: 2012

Journal Articles

Proteomic Exploration of the Cell Surface Landscape Reveals New Leukemia Associated Features.

Jean-Pierre Bourquin, MD, PhD, Paulina Mirkowska, MSc, Ester Mejstrikova, Lucie Slamova, MD, Tomasz Szczepanski, MD, PhD, Lukasz Sedek, PhD, Maike Schmitz, PhD, Vincent H.J. van der Velden, PhD, Andreas Hofmann, PhD, Gunnar Cario, MD, Martin Stanulla, MD, MSc, Beat C Bornhauser, PhD, Bernd Wollscheid, PhD

Blood (2012) 120 (21): 2506.

https://doi.org/10.1182/blood.V120.21.2506.2506

Published: 2012

Journal Articles

Intermediate-Risk Acute Lymphoblastic Leukemia (ALL) Patients with and without Relapse Differentially Depend on Survival Signals From Microenvironment

Peter Rhein, PhD, Rita Mitlohner, Renate Kirschner-Schwabe, PhD, Christian Hagemeier, MD, PhD, Gunnar Cario, MD, Martin Stanulla, MD, MSc, Martin Schrappe, MD, Iduna Fichtner, PhD, Richard Ratei, MD, Wolf-Dieter Ludwig, Leonid Karawajew, PhD

Blood (2011) 118 (21): 752.

https://doi.org/10.1182/blood.V118.21.752.752

Published: 2011

Journal Articles

Repeated Bone Marrow Aspiration At the End of Induction Therapy: Implications for Treatment Stratification in Paediatric Acute Lymphoblastic Leukaemia

Jan Zuna, MD, PhD, Mari Arens, Rolf Koehler, PhD, Renate Panzer-Grümayer, MD, Anja Möricke, MD, Claus R Bartram, MD, Ruth Joas, Eva Fronkova, Gunnar Cario, MD, Martin Stanulla, MD, MSc, Martin Zimmermann, PhD, Jan Trka, MD, PhD, Jan Stary, M.D., Andishe Attarbaschi, MD, Georg Mann, MD, Martin Schrappe, MD, André Schrauder, MD

Blood (2011) 118 (21): 756.

https://doi.org/10.1182/blood.V118.21.756.756

Published: 2011

Journal Articles

NOTCH1 Activation Neutralizes the Unfavorable Prognostic Effect of PTEN Mutations in BFM-Treated Children with T-ALL

Obul R Bandapalli, PhD, Corinne Kox, PhD, Martin Zimmermann, PhD, Martin Stanulla, MD, MSc, Martin Schrappe, MD, Wolf-Dieter Ludwig, Rolf Koehler, PhD, Martina U. Muckenthaler, PhD, Andreas E Kulozik, MD, PhD

Blood (2011) 118 (21): 740.

https://doi.org/10.1182/blood.V118.21.740.740

Published: 2011

Journal Articles

High CD45 (PTPRC) Expression Is Associated with An Overall Poor Outcome in Childhood Acute Lymphoblastic Leukemia Treated on the ALL-BFM 2000 Protocol and Exerts An Especially Pronounced Effect in Intermediate Risk Patients

Gunnar Cario, MD, Rita Mitlohner, Martin Zimmermann, PhD, Renja Romey, Peter Rhein, PhD, André Schrauder, MD, Anja Moericke, MD, Jean-Pierre Bourquin, MD, PhD, Wolf-Dieter Ludwig, MD, Richard Ratei, MD, Martin Schrappe, MD, Leonid Karawajew, PhD, Martin Stanulla, MD, MSc

Blood (2011) 118 (21): 742.

https://doi.org/10.1182/blood.V118.21.742.742

Published: 2011

Journal Articles

A Distinct DNA Methylation Pattern Characterizes Childhood Acute Lymphoblastic Leukemia and Separates Patients Into Prognostic Groups,

Stefanie Göllner, PhD, Anika Witten, PhD, Monika Stoll, PhD, Wolfgang E. Berdel, Martin Schrappe, MD, Gunnar Cario, MD, Martin Stanulla, MD, MSc, Carsten Müller-Tidow, MD

Blood (2011) 118 (21): 3568.

https://doi.org/10.1182/blood.V118.21.3568.3568

Published: 2011

Journal Articles

Evidence for Cooperation of Receptor Tyrosine Kinases and Activating NOTCH Mutations to Hyperactivate mTOR in T-Cell Leukemia: A Rationale Basis for Targeted Therapy

Adrian Schwarzer, MD, Johann Meyer, PhD, Martijn Brugman, PhD, Axel Schambach, MD PhD, Martin Stanulla, MD, MSc, Martin Schrappe, MD, Doris Steinemann, PhD, Brigitte Schlegelberger, M.D., Christopher Baum, MD, Zhixiong Li, MD

Blood (2011) 118 (21): 1381.

https://doi.org/10.1182/blood.V118.21.1381.1381

Published: 2011

Journal Articles

Major Improvement of Outcome in Pediatric High-Risk Acute Lymphoblastic Leukemia by Addition of BFM Chemotherapy Element “Phase IB”: A Comparative Data Analysis of Trials ALL-BFM 95 and ALL-BFM 2000

Anja Möricke, MD, André Schrauder, MD, Martin Zimmermann, PhD, Georg Mann, MD, Andishe Attarbaschi, MD, Rolf Koehler, PhD, Renate Panzer-Grümayer, MD, Martin Stanulla, MD, MSc, Gunnar Cario, MD, Alfred Reiter, MD, Felix Niggli, MD, Claus R Bartram, MD, Martin Schrappe, MD

Blood (2011) 118 (21): 1504.

https://doi.org/10.1182/blood.V118.21.1504.1504

Published: 2011

Journal Articles

IKZF1 Deletion Is An Independent Predictor of Outcome In Pediatric Acute Lymphoblastic Leukemia Treated According to the ALL-BFM 2000 Protocol

Petra Breithaupt, PhD, Barbara Meissner, MD, Martin Zimmermann, Anja Möricke, MD, André Schrauder, MD, Jochen Harbott, Wolf-Dieter Ludwig, MD, PhD, Rolf Köhler, PhD, Claus R Bartram, MD, Martin Schrappe, MD, Gunnar Cario, MD, Martin Stanulla, MD, MSc

Blood (2010) 116 (21): 409.

https://doi.org/10.1182/blood.V116.21.409.409

Published: 2010

Journal Articles

In Acute Lymphoblastic Leukaemia, Stemness Is Frequent and Ubiquitous

Klaus Rehe, MD, Kerrie Wilson, PhD, Simon Bomken, Hesta McNeill, Martin Stanulla, MD, MSc, Monique L. Den Boer, Julie Irving, PhD, Olaf Heidenreich, Josef Vormoor, MD

Blood (2010) 116 (21): 92.

https://doi.org/10.1182/blood.V116.21.92.92

Published: 2010

Journal Articles

Childhood Acute Lymphoblastic Leukemia: High Genomic Stability from Initial Diagnosis to Early Relapse.

Barbara Meissner, MD, Cornelia Eckert, PhD, Anja Moericke, MD, Arend von Stackelberg, MD, Renate Kirschner-Schwabe, PhD, Gunnar Cario, MD, André Schrauder, MD, Martin Zimmermann, PhD, Karl Welte, MD, Martin Schrappe, MD, Martin Stanulla, MD, MSc

Blood (2008) 112 (11): 1522.

https://doi.org/10.1182/blood.V112.11.1522.1522

Published: 2008

Journal Articles

High Interleukin 15 Expression Characterizes Childhood Acute Lymphoblastic Leukemia with Involvement of the Central Nervous System.

Gunnar Cario, MD, Anja Teichert, Peter Rhein, Andre Schrauder, MD, Julia Skokowa, MD PhD, Wolf-Dieter Ludwig, MD PhD, Shai Izraeli, MD, Karl Welte, MD PhD, Brigitte Schlegelberger, MD PhD, Martin Schrappe, MD PhD, Martin Stanulla, MD MSc

Blood (2006) 108 (11): 2270.

https://doi.org/10.1182/blood.V108.11.2270.2270

Published: 2006

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Cooperativity Of RUNX1 and CSF3R Mutations In The Development Of Leukemia In Severe Congenital Neutropenia: A Unique Pathway In Myeloid Leukemogenesis

Whole Exome Sequencing In Relapsed Pediatric T-ALL: Progression Into Relapse Is Characterized By An Increased Number Of Somatic Mutations and a Conservation Of Mutations In Leukemogenic Driver Genes

Second Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia

Novel Genomic Structural Variations in Relapsed Childhood ETV6/RUNX1 ( TEL/AML1 ) Acute Lymphoblastic Leukemias Identified by Next Generation Sequencing

Proteomic Exploration of the Cell Surface Landscape Reveals New Leukemia Associated Features.

Intermediate-Risk Acute Lymphoblastic Leukemia (ALL) Patients with and without Relapse Differentially Depend on Survival Signals From Microenvironment

Repeated Bone Marrow Aspiration At the End of Induction Therapy: Implications for Treatment Stratification in Paediatric Acute Lymphoblastic Leukaemia

NOTCH1 Activation Neutralizes the Unfavorable Prognostic Effect of PTEN Mutations in BFM-Treated Children with T-ALL

High CD45 (PTPRC) Expression Is Associated with An Overall Poor Outcome in Childhood Acute Lymphoblastic Leukemia Treated on the ALL-BFM 2000 Protocol and Exerts An Especially Pronounced Effect in Intermediate Risk Patients

A Distinct DNA Methylation Pattern Characterizes Childhood Acute Lymphoblastic Leukemia and Separates Patients Into Prognostic Groups,

Evidence for Cooperation of Receptor Tyrosine Kinases and Activating NOTCH Mutations to Hyperactivate mTOR in T-Cell Leukemia: A Rationale Basis for Targeted Therapy

Major Improvement of Outcome in Pediatric High-Risk Acute Lymphoblastic Leukemia by Addition of BFM Chemotherapy Element “Phase IB”: A Comparative Data Analysis of Trials ALL-BFM 95 and ALL-BFM 2000

IKZF1 Deletion Is An Independent Predictor of Outcome In Pediatric Acute Lymphoblastic Leukemia Treated According to the ALL-BFM 2000 Protocol

In Acute Lymphoblastic Leukaemia, Stemness Is Frequent and Ubiquitous

Childhood Acute Lymphoblastic Leukemia: High Genomic Stability from Initial Diagnosis to Early Relapse.

High Interleukin 15 Expression Characterizes Childhood Acute Lymphoblastic Leukemia with Involvement of the Central Nervous System.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only